Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Elicio Therapeutics, Inc. (ELTX) vs Lite Strategy, Inc. (LITS)

Elicio Therapeutics, Inc. and Lite Strategy, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Lite Strategy, Inc. are of similar size ($53.4M and $51.0M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against 152.9%. Across the 13 metrics below, Lite Strategy, Inc. leads on 7 and Elicio Therapeutics, Inc. on 6.

Valuation

Metric ELTX LITS Biotechnology median
P/E n/m n/m 7.88
P/S 1.23 0.49 11.47
P/B 4.46 0.90 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.78 0.42 10.73
Earnings yield (117.93%) (139.13%) (28.84%)
Free cash flow yield (106.74%) (20.24%) (23.03%)

Profitability

Metric ELTX LITS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (159.26%) (57.72%)
Return on assets (124.36%) (154.82%) (49.22%)
Return on invested capital 0.00% (73.66%) 0.00%

Growth

Metric ELTX LITS Biotechnology median
Revenue growth (TTM) 921.02% 152.90% 5.64%
EPS growth (last fiscal year) 39.29% (189.51%) —
Revenue growth, 5-year CAGR — 67.75% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX LITS Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 11.53 4.73
Net debt to EBITDA 0.25 1.05 0.96

Dividend

Metric ELTX LITS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ELTX LITS Biotechnology median
Market cap 53.35m 51.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack